Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dmitry Evseev

6PUBLICATIONS

134CO-AUTHORS

AutoimmunityMedical infection agents (incl. prions)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Apr 14, 2026

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.

Paul G Kemps, Jennifer L Picarsic, Sébastien Héritier

|Feb 12, 2026

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Jean Donadieu, Dmitry Evseev, Francesco Pegoraro

|May 22, 2023

Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.

Dmitry Evseev, Daria Osipova, Irina Kalinina

|Apr 21, 2022

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia.

Olga Goronkova, Galina Novichkova, Tatiana Salimova

|Nov 02, 2021

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Paul G Kemps, Jennifer Picarsic, Benjamin H Durham

|Aug 12, 2021

Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA.

Dmitry Evseev, Irina Kalinina, Elena Raykina

Pageof 1

Frequent Collaborators

3 joint publications

Michael Maschan

3 joint publications

Daria S Osipova

3 joint publications

Jean-François Emile

3 joint publications

Jean Donadieu

3 joint publications

Sébastien Héritier

2 joint publications

Jennifer Picarsic

2 joint publications

Laure Farnault

2 joint publications

Kee Kiat Yeo

2 joint publications

Bryan A Sisk

2 joint publications

Matthew Collin

Frequent Collaborators

3 joint publications

Michael Maschan

3 joint publications

Daria S Osipova

3 joint publications

Jean-François Emile

3 joint publications

Jean Donadieu

Top Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

$MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor$

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on : Dec 13, 2017

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

See more related videos

Top Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

$MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor$

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on : Dec 13, 2017

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

<i>Ex Vivo</i> Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on : Mar 29, 2024

See more related videos